SIMULTANEOUS MEASUREMENT OF SERUM 5-S-CYSTEINYLDOPA, CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN JAPANESE PATIENTS WITH MALIGNANT-MELANOMA
M. Hasegawa et al., SIMULTANEOUS MEASUREMENT OF SERUM 5-S-CYSTEINYLDOPA, CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN JAPANESE PATIENTS WITH MALIGNANT-MELANOMA, Melanoma research, 7(3), 1997, pp. 243-251
Citations number
31
Categorie Soggetti
Medicine, Research & Experimental",Oncology,"Dermatology & Venereal Diseases
Serum 5-S-cysteinyl dopa (5-S-CD), circulating intercellular adhesion
molecule-1 (cICAM-1) and soluble interleukin-2 receptor (sIL-2R) have
each been reported as useful markers for melanoma progression. To asse
ss the clinical relevance of these three markers, we simultaneously as
sayed their serum levels in 30 Japanese melanoma patients, Pre-surgica
l serum levels of 5-S-CD, cICAM-1 and sIL-2R were elevated in six, 13
and five patients respectively. These abnormal values returned to norm
al after curative surgery in most of the patients, suggesting a direct
relationship to the presence of the primary tumour. Presurgical value
s of these three markers, either individually or in combination, did n
ot predict the development of subsequent metastases. The sequential me
asurements of the three markers in eight patients who had relapse afte
r surgery showed that serum 5-S-CD is the most useful marker for disea
se progression, although it is dependent on the melanin-producing abil
ity of individual recurrent tumours. sIL-2R seemed to reflect in vivo
activation of the host immune system and was a good indicator for pred
icting occult metastasis in selected cases. Circulating ICAM-1 levels
were less relevant to the clinical disease course in our cases, althou
gh they tended to increase strikingly after liver metastasis. Our resu
lts in this limited number of cases show that the significance of the
three markers varied with the individual and suggest that the simultan
eous measurement of these markers may facilitate the early detection o
f metastases and proper therapeutic intervention.